Table 3. Clinical features, treatment and CEC counts for the PTC patients in G2.

No.	Gender	Age (year)	Histological variant	TNM stage	Surgery	Anti-TgAb (IU/ml)	Follow-up (year)	Cumulative RAI dose (mCi)	EpCAM+ (cell/ml)	TSHR+ (cell/ml)
1	F	52	Classical	T2N0M0	TT	< 10.00	2.3	60	2	17
2	F	36	Classical	T1N0M0	TT	< 10.00	9.1	60	5	10
3	F	48	Classical	T1N0M0	TT	< 10.00	11.6	30	10	15
4	F	44	Classical	T1N1M0	TT with LND	19.43	7.6	160	4	4
5	F	63	Classical	T1N0M0	ST	13.70	16.8	60	14	13
6	F	45	Classical	T1N0M0	TT	< 10.00	2.4	60	49	11
7	F	56	Classical	T1N0M0	TT	20.34	10.5	30	13	18
8	F	72	Classical	T1N0M0	TT	< 10.00	11.8	60	9	10
9	F	74	Classical	T2N0M0	TT	22.24	15.2	30	7	8
10	F	71	Classical	T1N0M0	ST	< 10.00	15.1	60	17	22
11	F	43	Classical	T1N0M0	ST	10.57	10.1	30	19	32
12	F	60	Classical	T1N0M0	TT	12.13	12.9	30	22	29
13	F	55	Classical	T1N0M0	TT	12.24	6.8	30	9	14
14	F	35	Classical	T3N0M0	TT	< 10.00	12.6	60	9	11
15	F	41	Classical	T1N0M0	TT	13.45	6.6	30	22	29
16	M	59	Classical	T3N0M0	TT with LND	< 10.00	5.5	60	5	1
17	M	48	Classical	T1N0M0	TT	13.28	2.7	60	14	17
18	M	63	Classical	T2N0M0	TT	11.27	16.0	90	16	18
19	M	58	Classical	T2N0M0	TT	21.36	6.8	30	16	19
20	M	60	Classical	T1N0M0	TT	11.99	12.4	60	8	8
21	F	55	FVPTC	T3N0M0	TT	12.30	3.7	60	14	38
22	F	57	FVPTC	T2N0M0	TT	13.46	9.5	30	15	24
23	F	64	Classical, multifocal	T1N0M0	TT	17.13	6.2	30	11	10
24	M	66	Classical, multifocal	T1N0M0	TT	13.21	5.0	60	7	4
25	F	53	FVPTC, multifocal	T1N0M0	TT	14.49	3.9	60	26	30
26	F	37	FVPTC, multifocal	T2N0M0	TT	17.67	8.2	30	2	24

Abbreviations: TT, total thyroidectomy; ST, subtotal thyroidectomy; LND, lymph-node dissection.